Investor List:

Top Therapeutics Seed Investors in San Francisco Bay Area (74)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Therapeutics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Alex Davidov, General Partner at Abstract Ventures
Alex Davidov
Abstract Ventures·General Partner
Sweet spot: $500K
Range: $250K - $750K
Investors in San Francisco (CA)
Investors in Insurance (Seed), Investors in Web3/Blockchain (Seed), Investors in BioTech (Seed), Investors in Web3/Crypto (Seed), Investors in Web3/Blockchain (Seed), Investors in BioTech (Seed), Investors in Web3/Crypto (Seed), Investors in FinTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Insurance (Seed), Investors in SaaS (Seed), Investors in Cybersecurity (Seed), Investors in Cybersecurity (Seed), Investors in Web3/Crypto (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in Insurance (Pre-seed), Investors in Cybersecurity (Pre-seed), Investors in BioTech (Pre-seed), Investors in SaaS (Pre-seed), Investors in FinTech (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in SaaS (Pre-seed), Investors in Insurance (Pre-seed), Investors in FinTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Cybersecurity (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in Angel, Scout, and Solo-Capitalists (Other Lists)
Photo of Josh Wolfe, Managing Partner at Lux Capital
Josh Wolfe
Lux Capital·Managing Partner
Sweet spot: $10.0M
Range: $1M - $50.0M
Investors in New York (NY), Investors in Menlo Park (CA)
Photo of Geoffrey Smith, Managing Partner at Digitalis Ventures
Geoffrey Smith
Digitalis Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA), Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Manufacturing (Series B), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health IT (Series B), Investors in Manufacturing (Series B), Investors in Health IT (Series B), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Dave Morin, Managing Partner at Offline Ventures
Dave Morin
Offline Ventures·Managing Partner
Sweet spot: $1M
Range: $500K - $5.0M
Investors in SF Bay Area (CA), Investors in California
Investors in Robotics (Seed), Investors in EnergyTech (Seed), Investors in Social Networks (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Space (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Web3/Crypto (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in BioTech (Seed), Investors in Consumer Internet (Seed), Investors in Web3/Crypto (Seed), Investors in EnergyTech (Seed), Investors in Consumer Internet (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Social Networks (Seed), Investors in Robotics (Seed), Investors in Space (Seed), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in DeepTech (Seed), Investors in EnergyTech (Pre-seed), Investors in DeepTech (Seed), Investors in DeepTech (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in Space (Pre-seed), Investors in Robotics (Pre-seed), Investors in Social Networks (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Consumer Internet (Pre-seed), Investors in AI (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Robotics (Pre-seed), Investors in Consumer Internet (Pre-seed), Investors in BioTech (Pre-seed), Investors in Therapeutics (Seed), Investors in Space (Pre-seed), Investors in Social Networks (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AI (Seed)
Photo of David Singer, Managing Partner at Maverick Capital
David Singer
Maverick Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Photo of Johnny Hu, Principal at Menlo Ventures
Johnny Hu
Menlo Ventures·Principal
Sweet spot: $12.0M
Range: $8.0M - $15.0M
Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Photo of Samuel Bjork, Partner at Digitalis Ventures
Samuel Bjork
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA)
Photo of Julia Moore, Managing Partner at Breakout Ventures
Julia Moore
Breakout Ventures·Managing Partner
Sweet spot: $3.0M
Range: $1M - $5.0M
Investors in SF Bay Area (CA)